LBPO.CH01 · 化学 · Late-Breaking

用于单个肿瘤细胞增殖表型及组学分析的一体化高通量检测

An integrated high-throughput assay for proliferative phenotypic and omics profiling of single tumor cells

海报缩略图:用于单个肿瘤细胞增殖表型及组学分析的一体化高通量检测
编号 LB029 展板 9 时间 4/19 02:00–05:00 区域 Section 51 主讲 Shiska Raut, BS;MS
分会场 Late-Breaking Research: Chemistry
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

Shiska Raut1, Karoliina Stefanius1, Bryan Presley1, Digant P. Dave2

1SingleCell Biotechnology, Dallas, TX,2University of Texas at Arlington, Arlington, TX

摘要 Abstract

中文摘要
由于缺乏可扩展的单细胞检测方法,测量细胞的再生潜能并解析其功能性生长异质性仍具挑战性。我们提出一种高通量检测平台,用于定量单细胞增殖潜能的表型以及所回收单细胞和克隆的相应组学状态。该检测可捕获单个肿瘤细胞的命运,涵盖从细胞死亡和休眠、到有限增殖、再到伴有三维克隆形成的强劲克隆扩增的连续谱。该平台将高密度、低黏附微孔板(标准96孔板格式,每孔含超过11,000个微孔)与机器学习驱动的图像分析流程相整合,实现对成千上万个空间受限单细胞的并行追踪。细胞以受控密度接种,使单个肿瘤细胞随机占据离散的微孔,并可随时间进行纵向追踪。在既定的检测终点,代表不同增殖状态的肿瘤细胞被选择性回收以用于下游组学分析。检测性能和可重复性在数千个微孔中得到评估,支持其稳健性以及适用于常规高内涵表型和组学筛选。使用三种在克隆形成能力上具有充分表征差异的胶质母细胞瘤(GBM)细胞系,我们证明了在多种孔板格式和成像平台上一致的单细胞占据率和高度可重复的命运分布。这种一体化的微尺度检测提供了一种可扩展且通用的方法,用于在单细胞分辨率下剖析增殖异质性,可应用于癌症生物学、治疗反应分析和功能性单细胞表型分析。通过在统一平台中解析增殖、有限分裂和休眠细胞命运,该方法为下一代单个肿瘤细胞的增殖表型及组学分析奠定了基础。
查看英文原文 English abstract
Measuring regenerative potential and resolving functional growth heterogeneity of cells remains challenging due to the lack of scalable single cell assays. We present a high throughput assay platform for quantifying phenotypic single cell proliferative potential and the corresponding omics states of retrieved single cells and colonies. The assay captures the fate of individual tumor cells spanning a continuum from cell death and dormant, to limited proliferation, to robust clonal expansion with 3D colony formation. The platform integrates high-density, low-adhesion microwell plates (standard 96-well format, with each well containing over 11, 000 microwells) with a machine learning-driven image analysis pipeline, enabling parallel tracking of tens and thousands of spatially confined single cells. Cells are seeded at controlled densities such that individual tumor cells stochastically occupy discrete microwells and can be longitudinally tracked over time. At defined assay endpoints, tumor cells representing distinct proliferative states are selectively recovered for downstream omics analysis. Assay performance and reproducibility were evaluated across thousands of microwells, supporting its robustness and suitability for routine high-content phenotypic and omics screening. Using three glioblastoma (GBM) cell lines with well characterized differences in clonogenic capacity, we demonstrate consistent single cell occupancy and highly reproducible fate distributions across multiple plate formats and imaging platforms. This integrated microscale assay provides a scalable and versatile approach for dissecting proliferative heterogeneity at single cell resolution, with applications in cancer biology, therapeutic response profiling, and functional single cell phenotyping. By resolving proliferative, limited-division, and dormant cell fates in a unified platform, this approach lays the foundation for next-generation proliferative phenotypic and omics profiling of single tumor cells.
利益披露 Disclosure
S. Raut, None.. K. Stefanius, None.. B. Presley, None.. D. P. Dave, None.

← 返回 AACR 2026 检索